Abstract
131I therapy may result in the patient becoming a hazard to other people. When a patient treated with 131I is hospitalized, caregivers must take special precautions to protect themselves against the radiation from the 131I in the patient. When patients are released immediately or shortly after treatment, they must take precautions to protect members of the public. Special governmental regulations affect the management of patients who are treated with 131I, and the physician administering the 131I must comply with these regulations. The treating physician must communicate to the patient the risk of radiation from the 131I treatment and any special precautions the patient should take to protect others. The patient should relay the information to the patient’s family, friends, and caretakers. Communication of precautions is challenging, and patients may forget what they have been told (Ong et al., Soc Sci Med 40:903–918, 1995). A balance must be achieved in convincing the patient to agree with these specific instructions and, at the same time, dispel unnecessary fear. For this balance, the physician may need to adopt different strategies with different patients, requiring a good working knowledge of radiation and radioactivity, ionizing and nonionizing radiation, and units of radioactivity and radiation dosage. The physician must also know the regulations for hospitalization, conditions for earlier release, radiation safety precautions during hospital stay and upon release, and the myths and fears about radioactivity. This chapter presents an overview of these topics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ong LM, de Haes JC, Hoos AM, Lammes FB. Doctor-patient communication: a review of the literature. Soc Sci Med. 1995;40:903–18.
Radiation and your patient: a guide for medical practitioners. Ann ICRP. 2001;2001:1–52.
National Research Council of the National Academies. Health effects from exposure to low levels of ionizing radiation: BEIR VII phase 2. Washington, DC: The National Academies Press; 2006.
Part 35, Medical use of byproduct material. Title 10, code of federal regulations, section 35.75.
Part G, Use of radionuclides in the healing arts. Suggested state regulations for control of radiation, vol. I, ionizing radiation. Conference of Radiation Control Program Directors. Inc.
Federal Register, 62 FR 4120, 29 Jan 1997.
Release of patients administered radioactive materials. Division 8, Occupational Health, Regulatory Guide 8.39, U.S. Nuclear Regulatory Commission, 1997. http://pbadupws.nrc.gov/docs/ML0037/ML003739575.pdf. Accessed 1 Jul 2014.
Ibis E, Wilson CR, Collier BD, et al. Iodine-131 contamination from thyroid cancer patients. Nucl Med. 1992;33:2110–5.
National Council on Radiation Protection and Measurements. Ionizing radiation exposure of the population of the United States. NCRP Report No. 160; Bethesda: NCRP. 2009.
International Atomic Energy Agency. Release of patients after radionuclide therapy. IAEA safety reports series No. 63. Vienna: IAEA; 2009 http://www-pub.iaea.org/MTCD/publications/PDF/pub1417_web.pdf. Accessed 1 Jul 2014.
Harolds JA. New scrutiny of outpatient therapy with I-131. Clin Nucl Med. 2011;36:206–8.
Sisson J, et al. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I: practice recommendations of the American Thyroid Association. Thyroid. 2011;121:335–46.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this chapter
Cite this chapter
Vetter, R.J., Glenn, J. (2016). Radiation and Radioactivity. In: Wartofsky, L., Van Nostrand, D. (eds) Thyroid Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3314-3_55
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3314-3_55
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-3312-9
Online ISBN: 978-1-4939-3314-3
eBook Packages: MedicineMedicine (R0)